Unspecified nephritic syndrome with diffuse crescentic glomerulonephritis
ICD-10 N05.7 is a billable code used to indicate a diagnosis of unspecified nephritic syndrome with diffuse crescentic glomerulonephritis.
Unspecified nephritic syndrome with diffuse crescentic glomerulonephritis is characterized by the presence of nephritic syndrome symptoms, including hematuria, proteinuria, and hypertension, alongside the histological finding of crescentic glomerulonephritis. This condition indicates a severe form of glomerular injury where crescent formations occur in the glomeruli, often leading to rapid progression to renal failure. Patients typically present with symptoms such as edema, oliguria, and elevated serum creatinine levels. The diagnosis is confirmed through renal biopsy, which reveals the presence of crescents in more than 50% of glomeruli. The etiology can be idiopathic or secondary to systemic diseases such as vasculitis or infections. Management often involves immunosuppressive therapy, including corticosteroids and cytotoxic agents, to reduce inflammation and prevent further renal damage. Close monitoring of renal function and regular follow-ups are essential to assess treatment efficacy and adjust management as needed.
Detailed clinical notes on symptoms, lab results, and renal biopsy findings.
Patients presenting with acute kidney injury and nephritic syndrome symptoms.
Ensure that all relevant laboratory and imaging studies are documented to support the diagnosis.
Comprehensive reports on renal biopsy findings, including the percentage of glomeruli affected.
Evaluation of renal biopsies in patients with suspected glomerulonephritis.
Pathology reports must clearly indicate the presence of crescents and any associated findings.
Used when a renal biopsy is performed to confirm crescentic glomerulonephritis.
Document the indication for biopsy, findings, and any complications.
Nephrologists must ensure that the biopsy results are clearly linked to the diagnosis.
Key symptoms include hematuria, proteinuria, hypertension, and edema. Patients may also experience oliguria and signs of acute kidney injury.
